RNA biotechnology

RNA Biotechnology is a biopharmaceutical company focused on the development of RNA-based therapeutics and molecular diagnostics for oncology and genetic diseases. The company leverages RNA interference (RNAi) and antisense technologies to target specific gene expressions involved in cancer progression, particularly focusing on BRCA-related pathways. Their research aims to provide personalized medicine solutions through innovative RNA-targeting platforms, bridging the gap between genetic testing and targeted therapy. The company's approach involves the use of small interfering RNAs to modulate the expression of genes that contribute to therapeutic resistance in hereditary cancers. By targeting the underlying genetic drivers of disease, RNA Biotechnology seeks to improve outcomes for patients with limited therapeutic options in the oncology space.